GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Take Solutions Ltd (NSE:TAKE) » Definitions » ROE % Adjusted to Book Value

Take Solutions (NSE:TAKE) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Take Solutions ROE % Adjusted to Book Value?

Take Solutions's ROE % for the quarter that ended in Mar. 2024 was 0.00%. Take Solutions's PB Ratio for the quarter that ended in Mar. 2024 was N/A. Take Solutions's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.


Take Solutions ROE % Adjusted to Book Value Historical Data

The historical data trend for Take Solutions's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Take Solutions ROE % Adjusted to Book Value Chart

Take Solutions Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.16 -56.75 -51.21 -38.04 -

Take Solutions Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -112.89 - -1.93 - -

Competitive Comparison of Take Solutions's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Take Solutions's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Take Solutions's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Take Solutions's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Take Solutions's ROE % Adjusted to Book Value falls into.



Take Solutions ROE % Adjusted to Book Value Calculation

Take Solutions's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-239.89% / N/A
=N/A

Take Solutions's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Take Solutions ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Take Solutions's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Take Solutions Business Description

Traded in Other Exchanges
Address
No.56, Dr. Radhakrishnan Salai, 4th Floor, Ragas Building, Mylapore, Chennai, TN, IND, 600004
Take Solutions Ltd is a technology-driven clinical research organization supporting pharma, biotech, and devices companies. It offers a combination of full-service Clinical Research, Generics Development, Data Sciences, Regulatory Affairs, and Pharmacovigilance and Safety services. The company operates in a single segment; Life Sciences and Support Services.

Take Solutions Headlines

No Headlines